Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Dennis Verducci"'
Autor:
Francesco Maura, Eileen Boyle, David Coffey, Kylee H Maclachlan, Benjamin Diamond, Patrick Blaney, Dylan Gagler, Bachisio Ziccheddu, Hussein Ghamlouch, Yubao Wang, James E. Hoffman, Dickran Kazandjian, Hani Hassoun, Emily Guzman, Sham Mailankody, Urvi A Shah, Carlyn Tan, Malin Hultcrantz, Michael Scordo, Gunjan L. Shah, Heather Landau, David J. Chung, Sergio A. Giralt, Yanming Zhang, Ahmet Dogan, Alexander M Lesokhin, Dennis Verducci, Faith E. Davies, Saad Usmani, Neha Korde, Gareth J. Morgan, Ola Landgren
Publikováno v:
Blood. 140:1137-1139
Autor:
Eileen M Boyle, Francesco Maura, David Coffey, Kylee H Maclachlan, Benjamin Diamond, Hussein Ghamlouch, Dylan Gagler, Patrick Blaney, Bachisio Ziccheddu, Yubao Wang, Emily Guzman, Avital Tenenbaum, Ariel Siegel, Xiaoyi Chen, Gaurav Varma, James E Hoffman, Dickran Kazandjian, Hani Hassoun, Sham Mailankody, Urvi A Shah, Carlyn Tan, Malin Hultcrantz, Michael Scordo, Gunjan L. Shah, Heather Landau, David J. Chung, Sergio A Giralt, Yanming Zhang, Ahmet Dogan, Alexander M Lesokhin, Dennis Verducci, Faith E Davies, Saad Usmani, Neha Korde, Ola Landgren, Gareth J. Morgan
Publikováno v:
Blood. 140:249-251
Autor:
Francesco Maura, Arjun Raj Rajanna, Andriy Derkach, Bachisio Ziccheddu, Niels Weinhold, Kylee H Maclachlan, Benjamin Diamond, Faith E. Davies, Eileen Boyle, Brian A. Walker, Alexandra M Poos, Malin Hultcrantz, Ariosto Siqueira Silva, Oliver Hampton, Jamie Teer, Niccolò Bolli, Graham Jackson, Martin F. Kaiser, Charlotte Pawlyn, Gordon Cook, Dennis Verducci, Dickran Kazandjian, Frits van Rhee, Saad Usmani, Ken H. Shain, Marc S Raab, Gareth J. Morgan, Ola Landgren
Publikováno v:
Blood. 140:1561-1563
Autor:
Neha Korde, Eric L. Smith, Francesco Maura, Malin Hultcrantz, Sydney X. Lu, Katie L. Thoren, Casey Piacentini, Angela Harrison, Elizabet Tavitian, Jenna Rispoli, Tala Shekarkhand, Urvi A Shah, Venkata Yellapantula, Aisara Chansakul, Ahmet Dogan, Heather Landau, Donna Massey, Hani Hassoun, Gunjan L. Shah, Dennis Verducci, Oscar B Lahoud, Sham Mailankody, Julia Schlossman, Kelly Werner, Carlyn Tan, Tim J Peterson, Andriy Derkach, Sean M. Devlin, Amanda Ciardiello, Michael Scordo, Kazunori Murata, Victoria Diab, Maria E. Arcila, David J. Chung, Alexander M. Lesokhin, Lakshmi V. Ramanathan, Katie Jones, Ola Landgren, Meghan Salcedo, Caleb Ho, Benjamin Diamond, Allison Sams, Even H Rustad, Mikhail Roshal, Sergio Giralt
Publikováno v:
Blood. 136:18-19
Background. Consensus from prior studies shows that the use of maintenance therapy after completion of combination therapy leads to longer progression-free survival (PFS) for patients with multiple myeloma with some studies showing an overall surviva
Autor:
Angela Harrison, Dennis Verducci, Lakshmi V. Ramanathan, Venkata Yellapantula, Ola Landgren, Isabel Concepcion, Ciardello Amanda, Carlyn Tan, Maria E. Arcila, David J. Chung, Neha Korde, Caleb Ho, Benjamin Diamond, Hani Hassoun, Gunjan L. Shah, Sydney X. Lu, Aisara Chansakul, Mikhail Roshal, Alexander M. Lesokhin, Urvi A Shah, Ahmet Dogan, Heather Landau, Sham Mailankody, Julia Caple, Julia Schlossman, Kelly Werner, Andriy Derkach, Oscar B Lahoud, Meghan Salcedo, Malin Hultcrantz, Sergio Giralt, Jenna Rispoli, Michael Scordo, Francesco Maura, Allison Sams, Kazunori Murata, Even H Rustad, Katie Jones, Elizabet Tavitian, Tala Shekarkhand, Katie L. Thoren, Casey Piacentini
Publikováno v:
Blood. 136:7-7
INTRODUCTION. Recent studies show that ~25% of newly diagnosed multiple myeloma patients treated with 8 cycles of bortezomib, lenalidomide and dexamethasone (VRd) achieve minimal residual disease (MRD) negativity. Recently, 42% stringent complete res
Autor:
Michael Scordo, Ahmet Dogan, Malin Hultcrantz, Jenna Rispoli, Oscar B Lahoud, Aisara Chansakul, Sydney X. Lu, Meghan Salcedo, Sham Mailankody, Francesco Maura, Neha Korde, Julia Schlossman, Allison Sams, Tala Shekarkhand, Elizabeth Tavitian, Kelly Werner, Even H Rustad, Amanda Ciardiello, Kazunori Murata, Caleb Ho, Victoria Diab, Urvi A Shah, Maria E. Arcila, David J. Chung, Heather Landau, Hani Hassoun, Katie Jones, Gunjan L. Shah, Sergio Giralt, Angela Harrison, Ola Landgren, Sean M. Devlin, Donna Mastey, Venkata Yellapantula, Mikhail Roshal, Eric L. Smith, Tim J Peterson, Alexander M. Lesokhin, Katie L. Thoren, Dennis Verducci, Lakshmi V. Ramanathan
Publikováno v:
Blood. 134:3127-3127
Background. Prior studies consistently show that the use of maintenance therapy after completion of combination therapy translates into longer progression-free survival (PFS) in patients with multiple myeloma. Some studies show that maintenance thera
Autor:
Sergio Giralt, Maria E. Arcila, David J. Chung, Michael Scordo, Dennis Verducci, Ahmet Dogan, Sham Mailankody, Hani Hassoun, Gunjan L. Shah, Oscar B Lahoud, Katie L. Thoren, Theresia Akhlaghi, Eric L. Smith, Heather Landau, Victoria Diab, Angela Harrison, Katie Jones, Neha Korde, Venkata Yellapantula, Sydney X. Lu, Malin Hultcrantz, Meghan Salcedo, Caleb Ho, Allison Sams, Even H Rustad, Ola Landgren, Alexander M. Lesokhin, Nikoletta Lendvai, Donna Mastey, Mikhail Roshal
Publikováno v:
Blood. 132:3281-3281
INTRODUCTION Using Carfilzomib, Lenalidomide and Dexamethasone (KRd) combination therapy in newly diagnosed multiple myeloma patients lead to ~40% minimal residual disease (MRD) negativity rate. Here, we use KRd in combination with daratumumab (DKRd)